Atypical Hemolytic Uremic Syndrome
Under a Creative Commons license
open access
Keywords
Complement
eculizumab
factor H
factor I
hemolytic uremic syndrome
membrane cofactor protein
thrombomodulin
transplantation
Cited by (0)
Financial support: supported by Wellcome Trust Intermediate Clinical Fellowships (A.R. and D.K.) Kidney Research UK (D.K.)
Conflict of interest statement: All authors have received fees from Alexion Pharmaceuticals for invited lectures and attendance at Global aHUS Advisory panel meetings. AR is named on the patent application (PCT/GB2010/002334) for recombinant factor H.
Copyright © 2013 Elsevier Inc.